|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Securities, at fair value(1)(2) | |||||||||||||||||||
| Loans, at fair value | |||||||||||||||||||
| Loans, at fair value(1)(2) | |||||||||||||||||||
| Loan commitments, at fair value | |||||||||||||||||||
| Forward MSR-related investments, at fair value(1) | |||||||||||||||||||
| Mortgage servicing rights, at fair value | |||||||||||||||||||
| Investments in unconsolidated entities, at fair value(1) | |||||||||||||||||||
| Real estate owned(1)(2) | |||||||||||||||||||
| Financial derivatives—assets, at fair value | |||||||||||||||||||
| Reverse repurchase agreements | |||||||||||||||||||
| Securities for Reverse Repurchase Agreements | |||||||||||||||||||
| Due from brokers | |||||||||||||||||||
| Investment related receivables(1) | |||||||||||||||||||
| Other assets(1) | |||||||||||||||||||
| Total Assets | |||||||||||||||||||
| Liabilities | |||||||||||||||||||
| Securities sold short, at fair value | |||||||||||||||||||
| Repurchase agreements(1) | |||||||||||||||||||
| Reverse mortgage loans | |||||||||||||||||||
| Total repurchase agreements(1) | |||||||||||||||||||
| Financial derivatives—liabilities, at fair value | |||||||||||||||||||
| Due to brokers | |||||||||||||||||||
| Investment related payables | |||||||||||||||||||
| Other secured borrowings(1) | |||||||||||||||||||
| Other secured borrowings, at fair value | |||||||||||||||||||
| Other secured borrowings, at fair value(1) | |||||||||||||||||||
| HMBS-related obligations, at fair value | |||||||||||||||||||
| Unsecured borrowings, at fair value | |||||||||||||||||||
| Base management fee payable to affiliate | |||||||||||||||||||
| Incentive Fee Payable | |||||||||||||||||||
| Dividends payable | |||||||||||||||||||
| Interest payable(1) | |||||||||||||||||||
| Accrued expenses and other liabilities(1) | |||||||||||||||||||
| Total Liabilities | |||||||||||||||||||
| ANALYSIS OF EQUITY: | |||||||||||||||||||
| Preferred stock, 100,000,000 shares authorized; 9,200,089 and 13,800,089 shares issued and outstanding, and $230,002 and $345,002 aggregate liquidation preference, respectively | |||||||||||||||||||
| Common stock, par value $0.001 per share, 300,000,000 shares authorized; 127,593,315 and 113,138,860 shares issued and outstanding, respectively | |||||||||||||||||||
| Additional paid-in-capital | |||||||||||||||||||
| Retained earnings (accumulated deficit) | |||||||||||||||||||
| Total Stockholders' Equity | |||||||||||||||||||
| Non-controlling interests(1) | |||||||||||||||||||
| Total Equity | |||||||||||||||||||
| Total Liabilities and Equity | |||||||||||||||||||
| Preferred Stock, Shares Authorized | |||||||||||||||||||
| Preferred Stock, Shares Outstanding | |||||||||||||||||||
Loading...
